TherapeuticsMD (TXMD) Misses Q2 EPS by 17c
TherapeuticsMD (NASDAQ: TXMD) reported Q2 EPS of ($0.24), $0.17 worse than the analyst estimate of ($0.07).
For earnings history and earnings-related data on TherapeuticsMD (TXMD) click here.
TherapeuticsMD (NASDAQ: TXMD) reported Q2 EPS of ($0.24), $0.17 worse than the analyst estimate of ($0.07).
For earnings history and earnings-related data on TherapeuticsMD (TXMD) click here.